The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > Hearing Tests

Hearing Tests

Hearing Tests are non-invasive evaluations used to assess an individual's auditory function.
These tests can measure various aspects of hearing, including sensitivity, acuity, and speech recognition.
They are commonly used to diagnose hearing disorders, determine the severity of hearing loss, and guide treatment options.
Hearing Tests may involve pure tone audiometry, speech audiometry, tympanometry, and other specialized procedures.
Theis comprehensive assessment helps healthcare providers develop personalized management strategies to improve a patient's overall hearing health and quality of life.

Most cited protocols related to «Hearing Tests»

Participants were given neuropsychological tests by a trained rater who was blind to diagnosis. Besides MMSE, a comprehensive neuropsychological battery involving memory, language, attention, executive function and visuospatial ability was used. The tests were as follows: the Auditory Verbal Learning Test (AVLT), the Rey-Osterrieth Complex Figure Test (CFT), the Boston Naming Test (BNT; the 30-item version), the Animal verbal fluency test (AFT), the Symbol Digit Modalities Test(SDMT), the STT (including Part A and B), the Stroop Color-Word Test (SCWT), the Similarity test, the Clock-drawing test (CDT), the CDR and HAMD. All tests have been proven to have a good reliability and validity in Chinese.
Full text: Click here
Publication 2013
Animals Attention Chinese Diagnosis Executive Function Hearing Tests Memory Mini Mental State Examination Neuropsychological Tests Stroop Test Visually Impaired Persons
Two groups of subjects were employed in this study. First, 42 clinically diagnosed AD subjects who had undergone MRI, FDG-PET and PIB-PET were used to create imaging biomarker cut-points. These AD subjects were drawn from our Alzheimer’s Disease Research Center (ADRC) or incident cases in the Mayo Clinic Study of Aging (MCSA). Second, all available cognitively normal (CN) subjects from the MCSA who had undergone MRI, FDG-PET, PIB-PET, and complete neuropsychological testing (n = 450) were used to both develop cognitive cut-points and to assess population frequencies of the different preclinical AD stages using different cut-point criteria.
The MCSA is a population-based study of cognitive aging that was established in Olmsted County, MN starting in October 2004 [7 (link)]. All MCSA subjects undergo a clinical and cognitive assessment every 15 months that includes 9 neuropsychological tests [7 (link)]. The evaluations of all subjects were reviewed by a consensus panel consisting of physicians (neurologists and geriatricians), neuropsychologists, and study nurses. Subjects in the present study were diagnosed by the consensus panel as being cognitively normal, based on the clinical assessments including mental status examinations and informant interviews as well as the neuropsychological testing battery described below [7 (link), 8 (link)].
The neuropsychological battery was constructed as previously described [7 (link), 8 (link)]. Domain specific measures are formulated from the Wechsler Adult Intelligence Scale-Revised (WAIS-R), Wechsler Memory Scale-Revised (WMS-R), Auditory Verbal Learning Test (AVLT), Trail Making Test (TMT), category fluency test, and Boston Naming Test (BNT). Four cognitive domains are assessed: Executive (TMT: Part B, WAIS-R Digit Symbol); Language (BNT, category fluency); Memory (WMS-R Logical Memory-II (delayed recall), WMS-R Visual Reproduction-II (delayed recall), AVLT delayed recall); and Visuospatial (WAIS-R Picture Completion, WAIS-R Block Design). Individual test scores were first converted to z-scores using the mean and standard deviation from the MCSA 2004 enrollment visit for subjects that were CN (n=1624). The individual z-scores were averaged to create 4 domain scores which were then also converted to z-scores. A global cognitive summary score was formed from the average of the 4 domain z-scores and then converted to a z-score by subtracting the mean and dividing by the standard deviation. This global summary score was used to assess cognitive impairment in our subjects.
Publication 2012
Adult Alzheimer's Disease Biological Markers Clinic Visits Cognition Disorders, Cognitive Fingers Geriatricians Hearing Tests Memory Mental Recall Neurologists Nurses Physical Examination Physicians Reproduction Respiratory Diaphragm
Participants were given neuropsychological tests by a trained rater who was blind to diagnosis. Except for the MMSE and MES, a comprehensive neuropsychological battery that included memory, language, attention, executive function and visuospatial ability was used. The tests were as follows: the Auditory Verbal Learning Test (AVLT) [29 ], the Rey-Osterrieth Complex Figure Test (CFT) [30 ], the Boston Naming Test (BNT; the 30-item version) [31 ], the Animal Fluency Test (AFT) [32 ], the Symbol Digit Modalities Test(SDMT) [33 ], the Trail Making Test-A and B (TMT-A, TMT-B) [34 ], the Stroop Color-Word Test (SCWT) [33 ], the Similarity test [35 ], the Clock-drawing test [6 (link)], the Clinical Dementia Rating (CDR) [22 (link)] and Center for Epidemiologic Studies Depression scale (CESD) [36 (link)]. All tests have been proven to have a good reliability and validity with those of a Chinese cultural background. Each patient with MCI or AD received a CT/MRI examination.
Full text: Click here
Publication 2012
Animals Attention Chinese Diagnosis Executive Function Hearing Tests Memory Mini Mental State Examination Neuropsychological Tests Patients Stroop Test Visually Impaired Persons
A total of 2470 participants were recruited, including 1151 cognitively normal controls (NC), 898 patients with amnestic mild cognitive impairment (aMCI), and 421 patients with mild Alzheimer disease (AD).
We recruited the controls using cluster sampling in Jingansi Community Shanghai, China. The inclusion criteria for NC were: age between 50 and 90; no memory complaints verified by an informant; cognitively normal, based on the absence of significant impairment in cognitive functions or activities of daily living (ADL); Clinical Dementia Rating (CDR)  =  0; and Hamilton depression rating scale (HAMD) scored ≤ 12 on the 17-item scale in past 2 weeks. They had adequate visual and auditory acuity to allow cognitive testing. Participants with any significant neurologic disease and psychiatric disorders/psychotic features were excluded.
All the patients with aMCI and AD were recruited from the Memory Clinic, Huashan Hospital, from Jun 2004 to Oct 2011.They finished the laboratory tests and cranial CT/MRI scan, and had no clinically significant abnormalities in vitamin B12, folic acid, thyroid function (free triiodothyronine-FT3, free tetraiodothyronine-FT4, thyroid stimulating hormone-TSH), rapid plasma regain (RPR), or treponema pallidum particle agglutination (TPPA).
The aMCI patients were diagnosed according to the following criteria19]: (1) cognitive complaints verified by an informant; (2) cognitive impairment lasting more than 3 months; (3) Mini-mental state examination-Chinese version (C-MMSE)[25] (link) ≥ cut-off score for adjusted education; (4) Abnormal objective memory impairment documented by scoring below the age and education adjusted cutoff on an episodic memory test (Auditory Verbal Learning Test); (5) preserved basic ADL/minimal impairment in complex instrumental functions; (6) etiology unknown; (7) normal sense of hearing and sight; (8) has not met diagnostic criteria of dementia based on the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA).
The AD patients (n = 421) met the following criteria: (1) diagnosed as probable AD according to the NINCDS-ADRDA; (2) no obvious medical, neurological or psychiatric diseases or psychological dysfunction including anxiety and depression within the previous one month; (3) no visual or auditory deficit.
Full text: Click here
Publication 2013
Agglutination Alzheimer's Disease Anxiety Auditory Perception Chinese Cognition Cognitive Impairments, Mild Congenital Abnormality Cranium Dementia Disorders, Cognitive Folic Acid Hearing Tests Liothyronine Memory Memory, Episodic Memory Deficits Mental Disorders Mini Mental State Examination Nervous System Disorder Patients Plasma Thyroid Gland Thyrotropin Treponema pallidum Vision Vitamin B12 X-Ray Computed Tomography
We presented pure tones as test stimuli (TS) simultaneously with band-eliminated noises (BENs) (Figures 1B, 2 and Additional file 1). The TS had a duration of 600 msec (10 msec rise and fall times), and a frequency of either 250, 350, 450, 570, 700, 840, 1000, 1170, 1370, 1600, 1850, 2150, 2500, 2900, 3400, or 4000 Hz (one critical band (CB) steps [29 ]). In 50% of trials, the TS contained a silent gap of 10 msec duration (with 10 msec rise and fall times) starting at latency 285 msec (deviant test stimulus, cf. Figure 2 and additional file 1). The TS with temporal gaps were targets for behavioral responses during the MEG measurement (reaction times and error rates) and ensured the subjects' compliance regarding the focus of attention. The sound onset asynchrony between two subsequent TS was fixed to 3000 msec.
The simultaneously presented BENs were prepared as follows: From 8000 Hz low-pass filtered white noise (sampling rate: 48000 Hz), spectral frequency bands with widths of either 1/4 critical band (1/4 CB), 1/2 critical band (1/2 CB), or 1 critical band (1 CB) centred at the frequency of the simultaneously presented TS were eliminated (Figure 2 and additional file 1). All BENs (duration 3000 msec; 10 msec rise and fall times) started 2200 msec prior to TS onset and ceased 200 msec after TS offset. All sound stimuli were prepared as sound files and presented under control of Presentation (Neurobehavioral Systems, Albany, CA, United States). 18000 Hz frequency tags (not perceivable) were attached to the onset of each TS in order to obtain precise timing. SRM-212 electrostatic earphones (Stax, Saitama, Japan) transduced air-conducted sounds which were delivered through silicon tubes (length: 60 cm; inner diameter: 5 mm) and silicon earpieces fitted to each subject's ears. The hearing threshold for the 1000 Hz TS was determined for each ear of each individual at the beginning of the MEG session. The 1000 Hz TS was presented binaurally at intensity of 35 dB above individual sensation level. The power of the other TS, which were also presented binaurally, was adjusted to the power of the 1000 Hz TS. The total power of the binaurally presented BENs was 15 dB larger than TS power, resulting in slightly higher spectrum levels for the BENs containing wider notches compared to the BEN with the narrowest notch (see Additional file 2; please note that the spectrum level difference is nearly invisible and therefore considered to be negligible).
In order to investigate the effects of stimulus sequencing during auditory focused attention, we contrasted two different conditions within subjects: 'constant sequencing' and 'random sequencing'. In the constant sequencing session, 30 TS with identical frequency (either solely 250, 350, 450, 570, 700, 840, 1000, 1170, 1370, 1600, 1850, 2150, 2500, 2900, 3400, or 4000 Hz) were successively (and pseudo-randomly) presented simultaneously with either the 1/4, 1/2, or the 1 CB BEN. In the random sequencing session, 30 TS with different frequencies were presented, pseudo-randomly chosen from the same frequencies that were used in the constant sequencing blocks (250, 350, 450, 570, 700, 840, 1000, 1170, 1370, 1600, 1850, 2150, 2500, 2900, 3400, or 4000 Hz). As in the constant sequencing condition, BENs with notches of either 1/4, 1/2, or 1 CB were presented simultaneously and pseudo-randomly (Figure 2 and additional file 1). Crucially, the overall amount of bottom-up auditory inputs was identical between constant sequencing and random sequencing conditions, while the patterning of stimuli was different. During all conditions, subjects were instructed to focus their attention on the auditory stimuli, and to press a response button as quickly as possible with their left or right index finger (randomized between subjects) whenever a TS with gap was detected. Constant sequencing and random sequencing blocks alternated, and block order was counterbalanced between subjects. In total, 160 trials (10 trials for 16 frequencies) for each BEN condition in each sequencing condition were presented and subjected to data analysis.
Full text: Click here
Publication 2009
Attention Auditory Perception Electrostatics Fingers Hearing Tests NOTCH4 protein, human One-Step dentin bonding system Silicon Sound

Most recents protocols related to «Hearing Tests»

MCSA participants underwent face‐to‐face evaluations including risk factor ascertainment (including NPI‐Q) and baseline evaluation (including Clinical Dementia Rating Scale) (19 (link)) performed by a nurse or study coordinator; a neurologic evaluation including a neurologic interview, Short Test of Mental Status (20 (link)), and neurologic examination performed by behavioral neurologists; and neuropsychological evaluation of four cognitive domains: memory (delayed recall trials from the Auditory Verbal Learning Test (21 ) and the Wechsler Memory Scale–Revised (22 ), Logical Memory and Visual Reproduction subtests); language (Boston Naming Test (23 ) and category fluency); visuospatial (Wechsler Adult Intelligence Scale–Revised (23 ), Picture Completion and Block Design subtests); and executive function (Trail Making Test Part B (24 (link)) and the Wechsler Adult Intelligence Scale–Revised (25 ), Digit Symbol subtest). All tests were administered by psychometrists and supervised by neuropsychologists. An expert consensus panel of physicians, neuropsychologists, and nurses or study coordinators reviewed the data and determined if a participant was CU, had MCI (based on the revised Mayo Clinic criteria (26 (link)) or dementia. In this analysis we included only individuals who were CU; participants with MCI or dementia were excluded for the current analysis at baseline. Classification of CU was based on normative data developed in this community (27 (link), 28 (link), 29 (link), 30 (link)).
We further created domain‐specific cognitive z‐scores by z‐scoring the averages of the test‐specific z‐scores, and additionally created a global z‐score by z‐scoring the averages of the domain‐specific z‐scores. The outcome of interest for the linear mixed‐effect model analyses was the longitudinal change in global and domain‐specific (i.e., memory, attention/executive function, language, visuospatial skills) cognitive z‐scores.
Publication 2023
Attention Cardiac Arrest Cognition Executive Function Face Fingers Hearing Tests Memory Mental Recall Neurologic Examination Neurologists Neuropsychological Tests Nurses Physicians Presenile Dementia Reproduction Systems, Nervous
The outcome was 12-, 24- and 36-month mortality following HF surgery. DDs diagnoses were based on current antidepressant treatment and Geriatric Depression Scale (GDS-15) scores (scores ≥ 5 indicate significant depressive symptoms) [24 ]. In addition, fluctuations of clinical state were observed and registered by the Organic Brain Syndrome scale (OBS scale) [25 (link)]. The GDS-15 has good sensitivity and specificity, even among very old people with low Mini Mental State Examination (MMSE) scores, for DDs detection according to the Diagnostic and Statistical Manual of Mental Disorders – Text revision (4.th ed.; DSM-IV-TR) [26 (link), 27 (link)]. Cognitive function was assessed using the MMSE, (scores 0–30, scores ≤ 23 indicate significant cognitive impairment) [28 ].
At the end of the RCTs, a consultant geriatrician (YG), blinded to group allocation and not employed at the wards, set all diagnoses. The consultant geriatrician used all possible information from patient’s medical record (diagnoses, complications, and other important documentations), patient’s prescribed drugs and assessments performed in these RCTs (including the MMSE, GDS- 15, Philadelphia Geriatric Center Morale Scale (PGCMS) [29 , 30 (link)], Katz ADL index, OBS Scale), as well as vision and hearing tests, to determine whether participants fulfilled the DMS-IV-TR criteria for DDs and dementia.
Full text: Click here
Publication 2023
Antidepressive Agents Cognition Consultant Dementia Depressive Symptoms Diagnosis Disorders, Cognitive Encephalopathies Geriatricians Hearing Tests Mini Mental State Examination Operative Surgical Procedures Patients Pharmaceutical Preparations Vision
We assessed the global cognitive function and the five cognitive domains (attention, executive function, language, memory, and visuospatial function) of all subjects. The global cognitive function was assessed using the mini-mental state examination (MMSE). Attention was tested by forward digit span test (DST). Language was assessed by Boston naming test (BNT). Memory was examined by auditory verbal learning test-HuaShan version (AVLT-H). Visuospatial function was evaluated by clock copying test (CCT).
Executive function was evaluated by trail making test (TMT) (inhibitory control), backward DST (working memory), clock drawing test (CDT) (planning and inhibitory control), semantic fluency test (SFT) (cognitive flexibility).
All patients were evaluated in the “ON” state, and those with scores 1.5 SD lower than the HC group were considered to have neuropsychological impairment. PD patients were classified using the diagnostic criteria recommended by Movement Disorder Society (MDS) of literature support as PD-MCI (Litvan et al., 2012 (link)) (n = 41) and PD-D (Emre et al., 2007 (link)) (n = 20). Those who did not fulfill criteria for PD-MCI or PD-D were classified as PD-N (n = 44).
Full text: Click here
Publication 2023
Attention Cognition Diagnosis Executive Function Fingers Hearing Tests Memory Memory, Short-Term Mini Mental State Examination Movement Disorders Patients Psychological Inhibition
According to the time characteristics of vestibular symptoms onset, patients can be classified into acute, episodic, or chronic vestibular syndrome (AVS, EVS, or CVS) (21 (link)). All diagnoses were made by the senior authors (ZXW and XY) according to widely accepted diagnostic criteria for each vestibular disorder or the international classification of vestibular disorders (ICVD) criteria when available (22 (link)–26 (link)). The published diagnostic criteria consensus includes acute unilateral vestibulopathy (AUVP)/VN (26 (link)), persistent postural-perceptual dizziness (PPPD) (23 (link)), VM (25 (link)), VM of childhood (24 (link)), and MD (22 (link)). Besides, probably labyrinthine infarction was diagnosed in older patients with sudden onset of unilateral deafness and vertigo, especially when there is a history of stroke or known vascular risk factors (27 (link)). Benign recurrent vertigo (BRV) was diagnosed when patients showed spontaneous rotational vertigo or instability; symptoms that were not triggered by changes in position, lasting longer than 1 min; normal audiogram or symmetric hearing loss; no cochlear symptoms (tinnitus or stuffiness) during the attack phase; no migraine or migraine aura in the acute phase (26 (link), 28 (link)). Isolated acute unilateral utricular vestibulopathy was diagnosed in patients with acute onset of postural imbalance, which can be diagnosed by ocular VEMP (26 (link)).
Full text: Click here
Publication 2023
Benign Paroxysmal Positional Vertigo Blood Vessel Cerebrovascular Accident Cochlea Deafness, Sudden Eye Hearing Impairment Hearing Tests Infarction Labyrinth Migraine Disorders Migraine with Aura Patients Syndrome Tinnitus Vertigo Vestibular Diseases Vestibular Labyrinth
All participants completed both visual and auditory tasks, in separate blocks, counterbalanced across participants. Each trial started with a 500-ms blank period (with no stimulus, besides the fixation point). Then, a visual or auditory test stimulus was presented. The duration of the test stimulus was one of five logarithmically spaced intervals of time, between 300 and 900 ms (i.e., 300, 395, 520, 684, 900 ms). Before beginning each block, participants were presented with five or more visual (or auditory) reference stimuli with duration 520 ms (the geometric mean of the test stimuli durations). They were instructed to remember the reference duration and to make subsequent judgments regarding test stimuli relative to the reference duration (the PSE values in Additional file 1: Fig. S6 confirm that participants indeed complied with this instruction). Before beginning the task, participants were allowed to continue to experience the reference stimulus repeatedly, until they were confident that they had remembered the reference duration. Once the block began, participants could no longer experience the reference stimulus.
Participants reported their choice on each trial after the stimulus had ended by pressing one of two keyboard buttons. The button-choice contingency was counterbalanced across participants: half the participants pressed the “F” button with their left index finger and the “J” button with their right index finger to indicate longer and shorter test durations, respectively, while the other half responded with the reverse mapping. Participants were instructed to make each response as quickly and accurately as possible. To ensure an equal number of consecutive stimulus pairs, while retaining a long-term pseudorandom structure, the order of stimulus presentation was determined by a pseudorandom 54 de Bruijn sequence. This creates an optimally short (pseudorandom) sequence of stimuli (625 trials total) in which each contiguous subsequence of 4 stimuli (from the 5 possible stimulus intervals) occurs exactly once [68 (link)]. Accordingly, each individual stimulus occurred 125 times, each possible pair occurred 25 times, each possible triplet occurred 5 times, and each quadruplet occurred once (per block).
Full text: Click here
Publication 2023
Auditory Perception Fingers Hearing Tests Quadruplets Self Confidence Triplets

Top products related to «Hearing Tests»

Sourced in United States, Denmark
The GSI 61 is a diagnostic instrument designed for audiometric testing. It is capable of performing a variety of audiological assessments, including pure-tone audiometry, speech audiometry, and immittance testing. The GSI 61 provides clinicians with the necessary tools to evaluate hearing function and aid in the diagnosis of hearing-related disorders.
Sourced in United States
The TympStar is a diagnostic device used for conducting tympanometry tests. It measures the middle ear's response to changes in air pressure, providing information about the condition of the tympanic membrane and middle ear function.
Sourced in Denmark
The AC40 is a clinical audiometer designed for comprehensive hearing assessments. It provides essential functionality for conducting pure-tone and speech audiometry, enabling healthcare professionals to evaluate an individual's hearing abilities.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in Germany, Denmark
The HDA 300 is a closed-back, over-ear headphone designed for use in laboratory and other critical listening environments. It features a frequency response of 8 Hz to 18 kHz and a maximum sound pressure level of 120 dB. The headphones have a nominal impedance of 150 ohms and a sensitivity of 110 dB SPL/V at 1 kHz.
Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in Germany
The Sennheiser HDA 200 headphones are high-quality audio monitoring headphones designed for use in professional audio environments. They feature a closed-back design and offer a frequency response of 8 Hz to 25 kHz. The headphones are equipped with 32 Ω impedance drivers and a 5-meter coiled cable for extended reach.
Sourced in United States
The ER 10B is a high-performance in-ear microphone system designed for accurate sound measurement and recording applications. It features a small, lightweight microphone that can be comfortably inserted into the ear canal to capture audio signals with precision.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Italy, Poland, India, Canada, Switzerland, Spain, China, Sweden, Brazil, Australia, Hong Kong
SPSS Statistics is a software package used for interactive or batched statistical analysis. It provides data access and management, analytical reporting, graphics, and modeling capabilities.

More about "Hearing Tests"

Auditory Assessments: Uncovering Hearing Health with Advanced Techniques Hearing tests, also known as audiological evaluations, are non-invasive procedures used to assess an individual's auditory function.
These comprehensive assessments employ a range of techniques, including pure tone audiometry, speech audiometry, tympanometry, and other specialized methods, to measure various aspects of hearing such as sensitivity, acuity, and speech recognition.
Audiologists and healthcare providers utilize these tests to diagnose hearing disorders, determine the severity of hearing loss, and develop personalized management strategies to improve a patient's overall hearing health and quality of life.
The insights gained from these assessments are crucial in guiding treatment options and ensuring the best possible outcomes for patients.
Advanced tools and technologies, such as the GSI 61 audiometer, TympStar tympanometer, AC40 clinical audiometer, and software like SAS version 9.4 and MATLAB, play a pivotal role in enhancing the accuracy and efficiency of hearing tests.
These sophisticated instruments and analytical platforms enable healthcare professionals to gather comprehensive data, analyze hearing function in-depth, and make informed decisions about patient care.
Additionally, specialized equipment like the HDA 300 and HDA 200 headphones, as well as the ER 10B insert earphones, ensure precise sound delivery and measurement during audiological assessments.
The integration of these advanced technologies with skilled clinicians and evidence-based protocols helps deliver a comprehensive, personalized approach to hearing healthcare.
By leveraging the insights gained from hearing tests and the latest advancements in audiological technology, healthcare providers can develop tailored management strategies to address the unique needs of each patient, ultimately improving their overall hearing health and quality of life.